Novocure Ltd.

This study tested a device that delivers electric fields to the tumor, combined with chemotherapy and immunotherapy, in 84 people with advanced pancreatic cancer who had not been treated before. The goal was to see if the combination could control the disease longer. While not a …

This study tested whether adding a device called Optune (which delivers electric fields to the brain) to standard radiation and chemotherapy could help people with newly diagnosed glioblastoma, a fast-growing brain tumor. About 981 adults took part. The goal was to see if the com…

This study tested a wearable device that delivers low-intensity electric fields (TTFields) to tumors, combined with standard chemotherapy, in 571 people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal was to see if adding TTFields helps people …